Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | VCP | P55072 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.43 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2295271 | 0.90 | SMN1; SMN2 (0.46) | GAANPSR1VCPNPC1FFAR1 | |
| SCHEMBL27967652 | 0.86 | LMNA (0.51) | GAANPSR1VCPTSHRMEN1 | |
| SCHEMBL28747451 | 0.85 | VCP (0.46) | GAAVCPMEN1KMT2ANPC1 | |
| SCHEMBL5680676 | 0.84 | TSHR (0.53) | NPSR1VCPTSHRMEN1KMT2A | |
| SCHEMBL9935172 | 0.84 | CA12 (0.50) | GAATSHRKMT2ANPC1RAB9A | |
| SCHEMBL9934062 | 0.83 | FFAR1 (0.59) | GAANPC1FFAR1RAB9AHTT | |
| SCHEMBL852379 | 0.82 | L3MBTL1 (0.44) | KMT2ARAB9ASMN1; SMN2TDP1 | |
| SCHEMBL2433672 | 0.82 | APP (0.45) | GAANPSR1MEN1KMT2ANPC1 | |
| SCHEMBL11544791 | 0.82 | ALDH1A1 (0.53) | NPC1 | |
| SCHEMBL2300644 | 0.82 | ACACB (0.44) | TSHRNPC1FFAR1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | claimed |
| US-20250382419-A1 | DISULFIDATED POLYMERS AND METHODS OF PREPARATION | UNIV COLORADO REGENTS (US) | 2025-12-18 | — | — | US | claimed |
| US-20240014444-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM BATTERY | ZHANGJIAGANG GUOTAI-HUARONG NEW CHEMICAL MATERIALS CO., LTD (CN) | 2024-01-11 | — | — | US | claimed |
| EP-4199168-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM BATTERY | Zhangjiagang Guotai-Huarong New Chemical Materials Co., Ltd (CN) | 2023-06-21 | — | — | EP | claimed |
| WO-2022111293-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM BATTERY | 张家港市国泰华荣化工新材料有限公司 | 2022-06-02 | — | — | WO | claimed |
| CN-110283180-B | Method for synthesizing pyridine [3,4-c ] coumarin | 长沙理工大学 | 2022-03-29 | — | — | CN | claimed |
| CN-111285751-B | Method for preparing alkene compound from alkyne compound | 中国科学院化学研究所 | 2021-06-01 | — | — | CN | claimed |
| EP-3504210-B1 | 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | HOFFMANN LA ROCHE (CH) | 2021-02-24 | — | — | EP | claimed |
| CN-111285751-A | Method for preparing alkene compound from alkyne compound | 中国科学院化学研究所 | 2020-06-16 | — | — | CN | claimed |
| CN-106380463-A | Method for synthesis of quinoline derivatives | 南阳师范学院 | 2017-02-08 | — | — | CN | claimed |
| CN-106380446-A | Synthesis method of quinoline-2-formic acid ester derivatives | 南阳师范学院 | 2017-02-08 | — | — | CN | claimed |
| CN-106366035-A | Method for synthesizing quinoline derivative | 南阳师范学院 | 2017-02-01 | — | — | CN | claimed |
| CN-106349147-A | Synthetic method of pyrrole derivatives | 南阳师范学院 | 2017-01-25 | — | — | CN | claimed |
| CN-103788137-B | Ferrocene piperidones compounds and preparation method thereof | NANKAI UNIVERSITY (CN) | 2016-05-11 | — | — | CN | claimed |
| CN-104003995-A | Pyrone-[3, 4-b] indole derivative and synthetic method thereof | UNIV SHANGHAI JIAOTONG | 2014-08-27 | — | — | CN | claimed |
| CN-103788137-A | Ferrocene piperidones compound and preparation method thereof | UNIV NANKAI | 2014-05-14 | — | — | CN | claimed |
| US-5663393-A | CYCLIZATION; DECYCLIZATION; HYDROLYSIS; HYDROGENATION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-09-02 | — | — | US | claimed |
| EP-0643626-A4 | CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL. | RES CORP TECHNOLOGIES INC (US) | 1995-12-06 | — | — | EP | claimed |
| EP-0643626-A1 | CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1995-03-22 | — | — | EP | claimed |
| WO-1993003838-A1 | CHIRAL CATALYSTS, CATALYTIC OXIDATION AND DISPROPORTIONATION REACTIONS, AND METHODS OF PRODUCING EPOXYCHROMANS AND TAXOL | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-03-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | GAA 1984/4885NPSR1 2821/4885VCP 3681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.